Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS031579-03
Application #
2269514
Study Section
Neurological Disorders Program Project Review A Committee (NSPA)
Project Start
1994-01-01
Project End
1998-12-31
Budget Start
1996-01-01
Budget End
1996-12-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Andreassen, Ole A; Dedeoglu, Alpaslan; Stanojevic, Violeta et al. (2002) Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression. Neurobiol Dis 11:410-24
Swerdlow, N R; Young, A B (2001) Neuropathology in Tourette syndrome: an update. Adv Neurol 85:151-61
Andreassen, O A; Ferrante, R J; Klivenyi, P et al. (2001) Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. Exp Neurol 168:356-63
Orlando, L R; Alsdorf, S A; Penney Jr, J B et al. (2001) The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Exp Neurol 167:196-204
Augood, S J; Hollingsworth, Z R; Standaert, D G et al. (2000) Localization of dopaminergic markers in the human subthalamic nucleus. J Comp Neurol 421:247-55
Klivenyi, P; Andreassen, O A; Ferrante, R J et al. (2000) Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurosci 20:7-Jan
Dunah, A W; Wang, Y; Yasuda, R P et al. (2000) Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 57:342-52
Jenkins, B G; Klivenyi, P; Kustermann, E et al. (2000) Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem 74:2108-19
Kuppenbender, K D; Standaert, D G; Feuerstein, T J et al. (2000) Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum. J Comp Neurol 419:407-21
Sapp, E; Penney, J; Young, A et al. (1999) Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 58:165-73

Showing the most recent 10 out of 104 publications